Company Search:
Advanced Search
Sponsored Links
Hikma Pharmaceuticals PLC Company Snapshot
Hikma Pharmaceuticals PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hikma Pharmaceuticals PLC with three other companies in this sector in the United Kingdom: Indivior Plc (2016 sales of £786.93 million [US$975.13 million] ), Croda International Plc (£1.24 billion [US$1.54 billion] ), and BTG Plc (£447.50 million [US$554.52 million] of which 37% was Licensing & Biotechnology).

Sales Analysis. Hikma Pharmaceuticals PLC reported sales of £1.45 billion (US$1.80 billion) for the year ending December of 2016. This represents an increase of 53.6% versus 2015, when the company's sales were £944.31 million. Sales at Hikma Pharmaceuticals PLC have increased during each of the previous five years (and since 2011, sales have increased a total of 154%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hikma Pharmaceuticals PLC
  Stock Performance Chart for Hikma Pharmaceuticals PLC
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 2,168.00p
(Figures in Pounds Sterling)
1 Week 1.4%   13 Weeks 6.6%  
4 Weeks 21.0%   52 Weeks 18.6%  
Hikma Pharmaceuticals PLC Key Data:
  Ticker: HIK Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,450,390,500
(Year Ending Jan 2017).
Employees: 7,189
  Currency: Pounds Sterling Market Cap: 5,202,643,236
  Fiscal Yr Ends: December Shares Outstanding: 239,974,319
  Share Type: Ordinary Closely Held Shares: 112,542,777
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.